Immune Nutrition for Nutritional and Immune Support in Head and Neck Cancer Patients During Radiotherapy
IMPACT
Head and Neck Neoplasms
+ Neoplasms
+ Neoplasms by Site
Treatment Study
Summary
Study start date: June 20, 2025
Actual date on which the first participant was enrolled.This study focuses on improving the nutrition and immune system of patients with head and neck cancer during their radiotherapy treatment. Head and neck cancer can often lead to poor nutrition because of its location, and radiotherapy can make this problem worse. This can affect the success of the treatment. While guidelines suggest early nutritional support for these patients, there is no clear direction on what type of nutrition works best. Immunonutrition, which involves nutrients that help the immune system, has shown potential in reducing side effects from radiotherapy and improving immune response. This study aims to explore the benefits of immunonutrition on patients' nutrition, immune health, and overall quality of life during their radiotherapy. In this study, 48 patients with head and neck cancer who are about to start radiotherapy are given a special nutrition formula containing arginine, omega-3 fatty acids, and nucleotides. This formula is designed to support their immune system. Patients receive this formula along with guidance from dietitians and nurses throughout their treatment. The study measures the impact of this nutrition on radiotherapy side effects like mouth sores and swallowing difficulties, as well as changes in nutritional health, immune markers, and quality of life. These factors are assessed at different stages: before treatment, halfway through, and after completing radiotherapy. This approach helps to determine if immunonutrition can make a meaningful difference during cancer treatment.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.48 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives